Agios Pharmaceuticals, Inc. announced that Jonathan Biller notified the Company of his intention to resign as chief financial officer on September 6, 2022, head of corporate affairs and principal financial officer of the Company, effective September 16, 2022, in order to pursue other opportunities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.34 USD | -3.20% | +15.37% | +63.18% |
28/05 | Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday | MT |
28/05 | Agios Pharmaceuticals to Sell 15% Vorasidenib Royalty Rights to Royalty Pharma for $905 Million | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.18% | 2.06B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- AGIO Stock
- News Agios Pharmaceuticals, Inc.
- Agios Pharmaceuticals, Inc. Announces Resignation of Jonathan Biller as Chief Financial Officer, Effective September 16, 2022